355
Views
13
CrossRef citations to date
0
Altmetric
Review

Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review

, , &
Pages 69-78 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matthew E. Falagas, Andreas D. Mavroudis & Konstantinos Z. Vardakas. (2016) The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?. Expert Review of Anti-infective Therapy 14:8, pages 747-763.
Read now
Lisa M. Blanchette, Joseph L. Kuti, David P. Nicolau & Michael D. Nailor. (2014) Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae. Scandinavian Journal of Infectious Diseases 46:11, pages 803-808.
Read now

Articles from other publishers (11)

Ruiqiu Zhao, Xiaoru Long, Jiangxia Wang, Jing Zhu, Cong Liu, Tingting Shang, Zhenzhen Zhang, Engels Obi, Lynda Osadebe, Yue Kang, Jie Liu, Xiaodi Chen & Hongmei Xu. (2022) Effectiveness of ertapenem for treatment of infections in children: An evidence mapping and meta-analysis. Frontiers in Pediatrics 10.
Crossref
Jin Ju Park, Eun-ju Jung, Jae-Young Kim, Yu Bin Seo, Jacob Lee & Younghee Jung. (2022) Thirty-Day Mortality Rates in Patients with Extended-Spectrum β-Lactamase-Producing Enterobacterales Bacteremia Receiving Ertapenem versus Other Carbapenems . Antimicrobial Agents and Chemotherapy 66:7.
Crossref
Dong Hoon Shin, Hyung-Sook Kim, Eunjeong Heo, Myoung-jin Shin, Nak-Hyun Kim, Hyunju Lee, Jeong Su Park, Kyoung Un Park, Jongtak Jung, Kyoung-Ho Song, Minsun Kang, Jaehun Jung, Eu Suk Kim & Hong Bin Kim. (2022) Stepwise Expansion of Antimicrobial Stewardship Programs and Its Impact on Antibiotic Use and Resistance Rates at a Tertiary Care Hospital in Korea. Microbiology Spectrum 10:3.
Crossref
Ryan Caputo, Alan Rozycki, Megan McClain, M. Mahdee Sobhanie, Kelci Coe, Nora Colburn & Lynn Wardlow. (2022) Clinical Outcomes with Ertapenem for Pneumonia in Obese versus Nonobese Patients. Antimicrobial Agents and Chemotherapy 66:1.
Crossref
Tiago Zequinão, João Paulo Telles, Juliano Gasparetto & Felipe Francisco Tuon. (2020) Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review. Revista da Sociedade Brasileira de Medicina Tropical 53.
Crossref
Pinyo Rattanaumpawan, Peerawong Werarak, Anupop Jitmuang, Pattarachai Kiratisin & Visanu Thamlikitkul. (2017) Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial. BMC Infectious Diseases 17:1.
Crossref
Barry Fox, Erin McAllister, Christian Holm, Jillian Handley & Lucas Schulz. (2016) Use of Ertapenem at an Academic Medical Center. Infectious Diseases in Clinical Practice 24:1, pages 43-48.
Crossref
Jesús Rodríguez-Baño, José Miguel Cisneros, Nazaret Cobos-Trigueros, Gema Fresco, Carolina Navarro-San Francisco, Carlota Gudiol, Juan Pablo Horcajada, Lorena López-Cerero, José Antonio Martínez, José Molina, Milagro Montero, José R. Paño-Pardo, Alvaro Pascual, Carmen Peña, Vicente Pintado, Pilar Retamar, María Tomás, Marcio Borges-Sa, José Garnacho-Montero & Germán Bou. (2015) Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology. Enfermedades Infecciosas y Microbiología Clínica 33:5, pages 337.e1-337.e21.
Crossref
J.D. Sun, S.F. Huang, S.S. Yang, S.L. Pu, C.M. Zhang & L.P. Zhang. (2015) Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. Clinical Microbiology and Infection 21:5, pages 469.e1-469.e10.
Crossref
Young Kyung Yoon, Kyung Sook Yang, Seung Eun Lee, Hyun Jeong Kim, Jang Wook Sohn & Min Ja Kim. (2014) Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship. PLoS ONE 9:6, pages e99101.
Crossref
Zubair A. Qureshi, Alveena Syed & Yohei Doi. (2014) Safety and Efficacy of Long-Term Outpatient Ertapenem Therapy. Antimicrobial Agents and Chemotherapy 58:6, pages 3437-3440.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.